美国制药分析测试外包Market Size, Share & Trends Analysis Report By Service (Bioanalytical Testing, Method Development & Validation, Stability Testing), By End-use, And Segment Forecasts, 2022 - 2030

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Services
1.1.2. End-use
1.2. Research Methodology
1.3. Information Procurement
1.3.1.购买的数据库
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Volume price analysis (Model 2)
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9.Objectives
1.9.1. Objective 1
1.9.2. Objective 2
1.9.3. Objective 3
1.9.4. Objective 4
Chapter 2. Executive Summary
2.1. Market Outlook
Chapter 3. U.S. Pharmaceutical Analytical Testing Outsourcing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. Increasing innovation in testing services
3.3.1.2. Regulation safety & quality
3.3.1.3. Pricing
3.3.2. Market restraint analysis
3.3.2.1. Data insecurity
3.3.2.2. Third-party performance
3.3.3. Penetration & Growth Prospect Mapping
3.3.4. Covid Impact Analysis
3.3.5. Major Deals and Strategic Alliances Analysis
3.3.6. Industry Analysis - Porter’s
3.3.7. Pestle Analysis
Chapter 4. U.S. Pharmaceutical Analytical Testing Outsourcing Market: Services Segment Analysis
4.1. U.S. Pharmaceutical Analytical Testing Outsourcing Market: Definition & Scope
4.2. U.S. Pharmaceutical Analytical Testing Outsourcing Market: Services Market Share Analysis, 2021 & 2030
4.3. Bioanalytical Testing
4.3.1. Bioanalytical Testing Market, 2018 - 2030 (USD Million)
4.3.2. Clinical
4.3.2.1. Clinical Market, 2018 - 2030 (USD Million)
4.3.3. Non-clinical
4.3.3.1. Non-clinical Market, 2018 - 2030 (USD Million)
4.4. Method Development & Validation
4.4.1. Method Development & Validation Market, 2018 - 2030 (USD Million)
4.4.2. Extractable & Leachables
4.4.2.1. Extractable & Leachables Market, 2018 - 2030 (USD Million)
4.4.3. Impurity Method
4.4.3.1. Impurity Method Market, 2018 - 2030 (USD Million)
4.4.4. Technical Consulting
4.4.4.1. Technical Consulting Market, 2018 - 2030 (USD Million)
4.4.5. Other Method Validation Services
4.4.5.1. Other Method Validation Services Market, 2018 - 2030 (USD Million)
4.5. Stability Testing
4.5.1. Stability Testing Market, 2018 - 2030 (USD Million)
4.5.2. Drug Substance
4.5.2.1. Drug Substance Market, 2018 - 2030 (USD Million)
4.5.3. Stability Indicating Method Validation
4.5.3.1. Stability Indicating Method Validation Market, 2018 - 2030 (USD Million)
4.5.4. Accelerated stability testing
4.5.4.1. Accelerated stability testing Market, 2018 - 2030 (USD Million)
4.5.5. Photostability Testing
4.5.5.1. Photostability testing Market, 2018 - 2030 (USD Million)
4.5.6. Other stability testing methods
4.5.6.1. Other stability testing Market, 2018 - 2030 (USD Million)
Chapter 5. U.S. Pharmaceutical Analytical Testing Outsourcing Market: End-use Segment Analysis
5.1. U.S. Pharmaceutical Analytical Testing Outsourcing Market: Definition & Scope
5.2. U.S. Pharmaceutical Analytical Testing Outsourcing Market: End-use Market Share Analysis, 2021 & 2030
5.3. Pharmaceutical companies
5.3.1. Pharmaceutical companies Market, 2018 - 2030 (USD Million)
5.4. Biopharmaceutical companies
5.4.1. Biopharmaceutical companies Market, 2018 - 2030 (USD Million)
5.5. Contract Research Organizations
5.5.1. Contract Research Organizations Market, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Company Profiles
6.1.1. West Pharmaceutical Services, Inc.
6.1.1.1. Company overview
6.1.1.2. Financial performance
6.1.1.3. Service benchmarking
6.1.1.4. Strategic initiatives
6.1.2. SGS SA
6.1.2.1. Company overview
6.1.2.2. Financial performance
6.1.2.3. Service benchmarking
6.1.2.4. Strategic initiatives
6.1.3. Eurofins Scientific
6.1.3.1. Company overview
6.1.3.2. Financial performance
6.1.3.3. Service benchmarking
6.1.3.4. Strategic initiatives
6.1.4. Pace Analytical Services Llc
6.1.4.1. Company overview
6.1.4.2. Financial performance
6.1.4.3. Service benchmarking
6.1.4.4. Strategic initiatives
6.1.5. Intertek Group PLC
6.1.5.1. Company overview
6.1.5.2. Financial performance
6.1.5.3. Service benchmarking
6.1.5.4. Strategic initiatives
6.1.6. Pharmaceutical Product Development, LLC.
6.1.6.1. Company overview
6.1.6.2. Financial performance
6.1.6.3. Service benchmarking
6.1.6.4. Strategic initiatives
6.1.7.无锡Apptec公司。
6.1.7.1. Company overview
6.1.7.2. Financial performance
6.1.7.3. Service benchmarking
6.1.7.4. Strategic initiatives
6.1.8. Boston Analytical
6.1.8.1. Company overview
6.1.8.2. Financial performance
6.1.8.3. Service benchmarking
6.1.8.4. Strategic initiatives
6.1.9. Charles River Laboratories International, Inc.
6.1.9.1. Company overview
6.1.9.2. Financial performance
6.1.9.3. Service benchmarking
6.1.9.4. Strategic initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 U.S. Pharmaceutical Analytical Testing Outsourcing Market, by Services, 2018 - 2030 (USD Million)
Table 4 U.S. Pharmaceutical Analytical Testing Outsourcing Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity Flow Analysis
Fig. 9 U.S. pharmaceutical analytical testing outsourcing market snapshot (2021)
Fig. 10 U.S. pharmaceutical analytical testing outsourcing: Market segmentation
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 SWOT analysis, by a factor (political & legal, economic and technological)
Fig. 16 U.S. Pharmaceutical Analytical Testing Outsourcing market service outlook: Segment dashboard
Fig. 17 U.S. pharmaceutical analytical testing outsourcing market: Service movement analysis
Fig. 18 Bioanalytical testing market, 2018 - 2030 (USD Million)
Fig. 19 Clinical market, 2018 - 2030 (USD Million)
Fig. 20 Non-clinical market, 2018 - 2030 (USD Million)
Fig. 21 Method development & validation market, 2018 - 2030 (USD Million)
Fig. 22 Extractable & leachable market, 2018 - 2030 (USD Million)
Fig. 23 Impurity method market, 2018 - 2030 (USD Million)
Fig. 24 Technical consulting market, 2018 - 2030 (USD Million)
Fig. 25 Others market, 2018 - 2030 (USD Million)
Fig. 26 Stability testing market, 2018 - 2030 (USD Million)
Fig. 27 Drug substance market, 2018 - 2030 (USD Million)
Fig. 28 Stability indicating method validation market, 2018 - 2030 (USD Million)
Fig. 29 Accelerated stability testing market, 2018 - 2030 (USD Million)
Fig. 30 Photostability testing market, 2018 - 2030 (USD Million)
Fig. 31 Other testing services market, 2018 - 2030 (USD Million)
Fig. 32 U.S. pharmaceutical analytical testing outsourcing market end-use outlook: Segment dashboard
Fig. 33 U.S. pharmaceutical analytical testing outsourcing market: End-use movement analysis
Fig. 34 Pharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 35 Biopharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 36 Contract research organizations market, 2018 - 2030 (USD Million)